Phillips & Cohen Articles on Whistleblower Issues

• “US Accelerates Pursuit of Companies for FCPA Violations,” Erika A. Kelton, Forbes.com, 12/23/16.
• “Wells Fargo CEO John Stumpf’s ‘Gutless Leadership’ Keeps Bank Mired in Mud,” Erika A. Kelton, Forbes.com, 9/28/16.
• “Look Who’s Bearing the Cost of Pharma’s Long-Time Sales and Marketing Tactics,” Erika A. Kelton, Forbes.com, 8/26/16.
• “LuxLeaks highlights need for whistleblower protection and incentives,” Erika A. Kelton, EurActiv.com, 7/25/16.
• “14.7 Billion Reasons Why Volkswagen Should Have Welcomed Whistleblowers,” Erika A. Kelton, Forbes.com, 6/29/16.
• “Seven Reasons Why Wall Street is Easy to Hate,” Erika A. Kelton, Forbes.com, 5/25/16.
• “Opinion: Quebec’s AMF should offer rewards to whistleblowers,” Stephen S. Hasegawa, Montreal Gazette, 3/30/16.
• “With Andrew Witty’s Departure, Will GlaxoSmithKline Say Goodbye to Fraud?” Erika A. Kelton, Forbes.com, 3/24/16.
• “Whistleblower Delivers a Triple Whammy to Olympus; More Companies Might Get Hit,” Erika A. Kelton, Forbes.com, 3/4/16.
• “VimpelCom’s Landmark Bribery Settlement – By The Numbers,” Erika A. Kelton, Forbes.com, 2/19/16.
• “Protecting Whistle-Blowers Against Retaliation,” Colette G. Matzzie, The New York Times, 2/10/16.
• “Stating a strong case for insurers using state whistleblower laws against fraudsters,” Peter Budetti and Colette G. Matzzie, Journal of Insurance Fraud in America, 1/15/16.
• “Rewarding whistleblowers,” Erika A. Kelton, The Economist, 1/2/16.
• “It’s Time to Stop Thinking of Whistleblowers as ‘Nut Jobs,'” Erika A. Kelton, Compliance Week, 12/29/2015.
• “IRS Whistleblower Program Has More Problems than the GAO Found,” Edward Arens, Accounting Today, 12/16/2015.
• “Pfizer-Allergan Merger Raises Concerns that Fraud is Part of ‘Corporate DNA,'” Erika A. Kelton, Forbes.com, 12/3/15.
• “Arrest in Allergan Division Case is Corporate Executives’ Worst Nightmare,” Erika A. Kelton, Forbes.com, 11/11/15.
• “Who’s Up Next? More Pharma Companies Expected to Settle Foreign Bribery Cases,” Erika A. Kelton, Forbes.com, 10/14/15.
• “Attack on SEC Rule for CEO Pay Disclosure is a Poor Shot,” Erika A. Kelton, Forbes.com, 8/13/15.
• “Everybody Does It: Convicted UBS Libor ‘Ringmaster’ Tells it Like it is on Wall Street,” Erika A. Kelton, Forbes.com, 8/7/16.
• “New strategy, technology emerging in ongoing fight against healthcare fraud,” Peter P. Budetti, Modern Healthcare, 7/18/2015.
• “Supreme Court Says No Free Pass For Qui Tam Defendants In False Claims Act Cases,” Colette G. Mattzie and Claire M. Sylvia, Law.com, 7/17/15.
• “Fixing Health Care,” Peter P. Budetti, The New Yorker, 6/29/15.
• “The Risk Adjustment Scoring Scam – A Medicare (Dis) Advantage,” Erika A. Kelton, Forbes.com, 6/17/15.
• “CEOs would pay attention to bonus clawbacks,” Erika A. Kelton, The Financial Times, 5/29/15. (PDF)
• “Amarin’s Lawsuit Could Have Huge Benefits for Pharma Industry and Dire Consequences for Consumers,” Erika A. Kelton, Forbes.com, 5/28/15.
• “Top 10 Not-to-be-Missed Quotes From the Forex Manipulation Scandal,” Erika A. Kelton, Forbes.com, 5/21/15.
• “Confidentiality Agreements Must Not Protect Crimes,” Erika A. Kelton and Stephen S. Hasegawa, The Wall Street Journal, 4/14/15. (PDF)
• “SEC Hits Back at KBR and Other Corporate Bullies Who Threaten Whistleblowers,” Erika A. Kelton, Forbes.com, 4/2/15.
• “UK clients can benefit from US whistleblower law,” Erika Kelton, Employment Lawyers Association Briefing, March 2015.
• “More Compliance, Fewer Complaints Needed From JPMorgan’s Jamie Dimon,” Erika A. Kelton, Forbes.com, 1/26/15.
• “The War on Dodd-Frank Whistleblowers – How Wall Street Gags, Intimidates and Fights the Fraud Fighters,” Erika A. Kelton, Forbes.com, 1/5/15.
• “CFTC Ready to Hammer Banks in Foreign-Exchange Probes,” Erika A. Kelton, Forbes.com, 11/11/14.
• “The SEC’s Secret Enforcement Weapon: Whistleblowers,” Stephen Hasegawa, Private Funds Management, 8/6/2014.
• “BNP Paribas Case Teaches Bank Lesson, But Not the Right One,” Erika A. Kelton, Forbes.com, 7/8/14.
• “The SEC Puts Teeth Into Dodd-Frank, Takes a Bite for Whistleblowers,” Erika A. Kelton, Forbes.com, 6/27/14.
• “Loose Fingertips Sink Wall Street Ships: Traders’ Online Conversations Have Deutsche Bank Worried,” Erika A. Kelton, Forbes.com, 5/29/14.
• “GlaxoSmithKline’s Spin Doctoring Doesn’t Cure Corruption Problems,” Erika A. Kelton, Forbes.com, 4/28/14.
• “IRS Cheats Taxpayers by Ignoring Whistleblowers,” Erika A. Kelton, Forbes.com, 4/8/14.
• “The lurking risks of hospital-employed physicians: Stark, Anti-Kickback and False Claims Act compliance,” Peter W. Chatfield, Healthcare Finance News, 3/25/2014.
• “SEC Ready to Rumble in Siemens Whistleblower Case,” Erika A. Kelton, Forbes.com, 3/4/14.
• “CFTC Will Flex Dodd-Frank Muscle in 2014,” Erika A. Kelton, Forbes.com, 2/19/14.
• “Snowden Has Major Impact on Whistleblower Case,” Erika A. Kelton, Forbes.com, 1/24/14.
• “UK Support For Glaxo But None For Whistleblowers?” Erika A. Kelton, Forbes.com, 12/26/13.
• “Putting a Dollar Value on Whistleblowers,” Erika A. Kelton, Forbes.com, 10/19/13.
• “Medicare Blood Money: The Healthcare Industry’s Misalignment of Profits and Humane Medical Treatment,” Erika A. Kelton, Forbes.com, 9/12/13.
• “Is Big Pharma Addicted to Fraud?” Erika A. Kelton, Forbes.com, 7/29/13.
• “Is a Whistleblower Behind Investigation of Contractor That Vetted Snowden?” Erika A. Kelton, Forbes.com, 7/15/13.
• “SEC Whistleblower Rewards: Large Ones Are Coming,” Erika A. Kelton, Forbes.com, 6/26/13.
• “Filthy Pharma: Justice Department Taking ‘Especially Hard Look’ at Manufacturing Plants,” Erika A. Kelton, Forbes.com, 6/6/13.
• “Jamie Dimon Gets What He Wants, But Is It Best For JPMorgan?” Erika A. Kelton, Forbes.com, 5/21/13.
• “The Tea Party and IRS Controversy: More Scrutiny Needed – Not Less,” Erika A. Kelton, Forbes.com, 5/16/13.
• “Anonymous Whistleblower Behind Expose of Massive Offshore Corruption by Banks and Others,” Erika A. Kelton, Forbes.com, 4/5/13.
• “IRS Uses the Sequester to Give Whistleblowers Another Kick in the Teeth,” Erika A. Kelton, Forbes.com, 3/6/13.
• “U.S. vs. Lance Armstrong: Understanding the Latest in the Floyd Landis Whistleblower Case,” Erika A. Kelton, Forbes.com, 2/27/13.
• “Five Lessons Corporations Can Learn From the Westminster Dog Show,” Erika A. Kelton, Forbes.com, 2/13/13.
• “JPMorgan and Jamie Dimon Need an Extreme Makeover,” Erika A. Kelton, Forbes.com, 1/25/13.
• “The Whistleblower Lawsuit Against Lance Armstrong: What to Expect Next,” Erika A. Kelton, Forbes.com, 1/17/13.
• “Off-Label Pharma Prosecutions Won’t Be Silenced By First Amendment Decision,” Erika A. Kelton, Forbes.com, 1/4/13.
• “FDA’s Campaign to Control the Practice of Medicine,” Erika A. Kelton, The Wall Street Journal, 1/3/13. (PDF)
• “Barclays’ Traders Show How Much Fun Wall Street Has Manipulating Markets,” Erika A. Kelton, Forbes.com, 11/20/12.
• “Hang It Up, Wall Street. Dodd-Frank is Here to Stay,” Erika A. Kelton, Forbes.com, 11/13/12.
• “Gupta Sentence: Charity Work Too Good for Wall Street Criminals,” Erika A. Kelton, Forbes.com, 10/24/12.
• “IRS Whistleblowers Should See New Tone at the Top,” Erika A. Kelton, Forbes.com, 10/11/12.
• “Big Pharma’s Offshore Fraud Strategy,” Erika A. Kelton, Forbes.com, 9/11/12.
• “The Bane of Romney’s Investments: Whistleblowers,” Erika A. Kelton, Forbes.com, 8/20/12.
• “‘Dead Wrong,’ JPMorgans’ Dimon Should Make Voluntary Clawback,” Erika A. Kelton, Forbes.com, 7/17/12.
• “Whistleblower Case Against GE, New Report Show Real Motives for Attacks on SEC Program,” Erika A. Kelton, Forbes.com, 6/6/12.
• “To Cut California’s Budget Gap, Cut One Sentence from State Whistleblower Law,” Erika A. Kelton, Forbes.com, 5/21/12.
• “More Drug Companies to Pay Billions for Fraud, Join the ‘Dishonor Roll’ After Abbott Settlement,” Erika A. Kelton, Forbes.com, 5/10/12.
• “Keep Heat on IRS Commissioner Shulman; Whistleblowers Needed to Uncover Offshore Tax Abuses,” Erika A. Kelton, Forbes.com, 5/7/12.
• “Can the SEC be trusted to protect a whistleblower’s identity?”, Erika A. Kelton, Forbes.com, 4/27/12.
• “The Tax Whistleblower Case Against Spring: NY Attorney General Gets It, the IRS Doesn’t,” Erika A. Kelton, Forbes.com, 4/20/12.
• “J&J Needs a Cure: New CEO Allegedly Had Links to Fraud,” Erika A. Kelton, Forbes.com, 4/17/12.
• “Fraud Shouldn’t Be So Rewarding,” Erika A. Kelton, Forbes.com, 4/2/12.
• “Seven Ingredients For a Successful Whistleblower Program,” Erika A. Kelton, Forbes.com, 3/21/12.
• “Olympus Fraud Shows More Countries Need Whistleblower Reward Laws,” Erika A. Kelton, Forbes.com, 3/13/12.
• “IRS Whistleblowers See Little Reward,” Erika A. Kelton, Forbes.com, 3/2/12.
• “Whistle Stop,” Erika A. Kelton, The New York Post, 2/26/11. (PDF)
• “SEC whistleblower program worth protecting,” Erika A. Kelton, The Washington Post, “Capital Business,” 12/13/2010.
• “Whistleblower program (Corporations are right to fear the power of the whistleblower program),” Erika A. Kelton, National Law Journal, 11/22/10.
• “Most whistleblowers have ‘clean hands,'” Erika A. Kelton, Financial Times, 8/11/2010. ( PDF)
• “Keep the cheese out of it,” Erika A Kelton, The Washington Post, 7/31/10. (PDF)
• “Bridge the Tax Gap: Bringing in the Whistleblowers,” Erika A. Kelton, Capitol Weekly, 5/6/2010.
• “Korb wrong about whistleblower program, writer says,” Erika A. Kelton, Tax Analysts, 1/21/10.
• “Whistleblower bounty must go hand-in-hand with reform,” Erika A. Kelton, Financial Times, 7/6/09. (PDF)
• “Encouraging whistleblowers, discouraging fraud,” Erika A. Kelton, Washington Post, 3/21/09. (PDF)
• “To catch a tax cheat,” Erika A. Kelton, International Herald Tribune, 8/7/08.
• “Mind the (tax) gap,” Erika A. Kelton, Pharmaceutical Executive, 4/1/08.
• “Qui tam suits and you,” Erika A. Kelton, Drug Topics, 3/20/2006.
• “Qui tam lawsuits blow the whistle on PBMs,” Erika A. Kelton, Pharmacy Times, January 2006.
• “Environment is new target of qui tam lawsuits,” Lisa Foster, Toxics Law Reporter, July 2000.
• “The False Claims Act and Wall Street: How a qui tam case reformed the municipal bond market,” Erika Kelton, False Claims Act and Qui Tam Quarterly Review, July 2000.
• “A better road for whistleblowers,” John R. Phillips & Mary Louise Cohen, The New York Times, 9/26/99.
• “Privatizing customs fraud enforcement under the False Claims Act,” Erika Kelton, International Trade Reporter, 5/12/99.
• “Blowing the whistle on customs fraud,” Erika Kelton, Journal of Commerce, 3/18/1999.
• Healthcare provider’s guide to whistleblower lawsuits & the False Claims Act, Phillips & Cohen, Washington G-2 Reports, 1997.
• “False claims can result in prison time, fines,” John R. Phillips and Mary Louise Cohen, Healthcare Risk Management, June 1997.
• “Failure to disclose Medicare overpayments or accurate information can result in jail time for false claims,” John R. Phillips and Mary Louise Cohen, Health Care Fraud Litigation Reporter, June 1997.
• “Failing to report Medicare billing errors: a very risky business,” John R. Phillips and Mary Louise Cohen, New Perspectives (Journal of the Association of Healthcare Internal Auditors), Spring 1997.
• “Civil War-era law attacking false Medicare claims,” John R. Phillips and Mary Louise Cohen, Healthcare Risk Management, March 1997.
• “How to avoid liability under the False Claims Act,” John R. Phillips and Mary Louise Cohen, American Medical News, February 10, 1997.
• “The False Claims Act in practice,” John R. Phillips, California Lawyer , August 1991.
• “Changing the rules to plunder in procurement,” John R. Phillips, The Wall Street Journal, April 22, 1986.